Clinical Trials Related to Merck Sharp & Dohme LLC

Related studies linked through entity extraction aliases.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001)

Status: COMPLETED
Phase: PHASE3

Niacin (+) Laropiprant (TREDAPTIVE) Re-examination Study (MK-0524A-119)

Status: TERMINATED
Phase: N/A

Placebo Controlled Study of Preladenant in Participants With Moderate to Severe Parkinson's Disease (P07037)

Status: COMPLETED
Phase: PHASE3

A Phase I Study of MK-4827 for Treatment of Solid Tumors (MK-4827-005)

Status: TERMINATED
Phase: PHASE1

Erbitux Study of CPT11, Oxaliplatin, UFToral Targeted Therapy

Status: COMPLETED
Phase: PHASE2

A Study to Determine the Optimal Dose of Tildrakizumab (SCH 900222/MK-3222) for the Treatment of Moderate-to-severe Chronic Plaque Psoriasis (P05495) (MK-3222-003)

Status: COMPLETED
Phase: PHASE2

Evaluation of Pharmacokinetics, Safety, And Tolerability Of Ertugliflozin (PF-04971729, MK-8835) In Japanese And Western Healthy Participants (MK-8835-041)

Status: COMPLETED
Phase: PHASE1

The Growth Factor Signature (GFS) as an Intermediate Biomarker of Response for Development of PI3K-Pathway Inhibitors in Patients With Breast Cancer (MK-8669-050)

Status: COMPLETED
Phase: PHASE1

A Four Week, Open-Label Study of Azithromycin Ophthalmic Solution, 1% (P08641)

Status: TERMINATED
Phase: PHASE2

Evaluation of Anti-mullerian Hormone Levels as Predictive of IVF Outcomes in Women Over 38 Years Old

Status: COMPLETED
Phase: N/A

Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)

Status: COMPLETED
Phase: N/A

A Dose-Range Finding Study in Participants With Type 2 Diabetes (MK-3102-006)

Status: COMPLETED
Phase: PHASE2

An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153)

Status: TERMINATED
Phase: PHASE3

A Study of Pneumococcal Conjugate Vaccine (V114) Compared to a Marketed Vaccine (V114-003)

Status: COMPLETED
Phase: PHASE2

Safety and Tolerability Study for the Pneumococcal Conjugate Vaccine V114 Versus Prevnar™ (V114-001)

Status: COMPLETED
Phase: PHASE1

Truvada Plus Raltegravir for Nonoccupational Post-exposure Prophylaxis (nPEP)

Status: COMPLETED
Phase: PHASE4

A Study to Assess the Efficacy of Raltegravir (Isentress®), Administered in Combination With Other Antiretroviral Drugs as Treatment for Adults and Older Adults Infected With the Human Immunodeficiency Virus 1 (HIV-1)(MK-0518-145) (Wirksamkeit Von Isentress® Unter Praxisbedingungen)

Status: COMPLETED
Phase: N/A

Observational Study to Evaluate the Current Neuromuscular Monitoring Practice Used After Different Types of Surgery, for Which Neuromuscular Blocking Agents Were Used, With or Without Blocking Reversal (P06556)

Status: COMPLETED
Phase: N/A

Telephone Based Management of Hyperlipidemia

Status: COMPLETED
Phase: PHASE4

Acute Effect of Mometasone on Beta-adrenergic Airway and Airway Vascular Relaxation in Severe Asthma

Status: COMPLETED
Phase: NA